Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial
NCT ID: NCT01810224
Last Updated: 2013-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
206 participants
INTERVENTIONAL
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Preoperative FFR on Arterial Bypass Graft Functionality
NCT02527044
iFR Guided Coronary Artery Bypass Grafting Surgery
NCT04014140
CABG Based on CT-FFR Versus Conventional Coronary Angiography
NCT06028165
Graft Patency of QFR-guided Versus Angio-guided Coronary Artery Bypass Grafting
NCT03770520
Using Intraoperative Coronary Bypass Graft Imaging to Improve Graft Patency
NCT00187421
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Angio-guided arm
In this arm will be included the patient randomized to a Angiography-guided surgical revascularization strategy.
Surgical revascularization
The final intervention (surgical revascularization) will be the same for both arms.
FFR-guided arm
In this arm will be included the patient randomized to a FFR-guided surgical revascularization strategy.
Surgical revascularization
The final intervention (surgical revascularization) will be the same for both arms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical revascularization
The final intervention (surgical revascularization) will be the same for both arms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Significant LAD and/or LM lesion - proved by FFR or Angiography AND
* At least one more, angiographycally intermediate lesion
Exclusion Criteria
* Severe left ventricular dysfunction (EF\<35%)
* Acute STEMI
* Atrial fibrillation, if Maze procedure is planned
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Onze Lieve Vrouw Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emanuele Barbato
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emanuele Barbato, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cardiovascular Center Aalst, OLV Hospital, Aalst (Belgium)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular Center Aalst OLV Hospital
Aalst, , Belgium
Department of Internal Medicine and Cardiology, University Hospital Brno
Brno, , Czechia
Hungarian Institute of Cardiology
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. EuroIntervention. 2019 Dec 6;15(11):e999-e1005. doi: 10.4244/EIJ-D-19-00463.
Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R, Piroth Z, Fournier S, Van Mieghem C, Penicka M, Mates M, Van Praet F, Degriek I, Barbato E. Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI). J Cardiovasc Transl Res. 2018 Aug;11(4):269-273. doi: 10.1007/s12265-018-9818-9. Epub 2018 Jul 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRAFFITI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.